is semaglutide fda approved for mash Live Updates on Semaglutide's Current and Future Uses FDA Approves Semaglutide to Treat

The patient risk assessment included body mass index in kg/m2 (BMI), and medical history regarding diabetes mellitus (DM), gastroesophageal reflux disease (GERD), hiatal hernia (HH), and narcotic use

Research from the STEP 9 study, reported at the World Congress on Osteoarthritis, discovered additional benefits of semaglutide

Dawn Ericsson, MD, alongside a team that includes nurse practitioners and patient care advisors

However, this is not a universal or first-line weight loss solution, and it should never be used without proper medical guidance

This is particularly noteworthy because two competing oral small-molecule GLP-1 programs from Pfizer, lotiglipron (discontinued in 2023) and danuglipron (discontinued in April 2025), were terminated due to liver toxicity concerns